Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update

Glioblastoma multiforme (GBM) is the most common and malignant brain tumor with poor prognosis. The heterogeneous and aggressive nature of GBMs increases the difficulty of current standard treatment. The presence of GBM stem cells and the blood brain barrier (BBB) further contribute to the most impo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2021-01, Vol.13 (2), p.195
Hauptverfasser:	Hsu, Jen-Fu, Chu, Shih-Ming, Liao, Chen-Chu, Wang, Chao-Jan, Wang, Yi-Shan, Lai, Mei-Yin, Wang, Hsiao-Chin, Huang, Hsuan-Rong, Tsai, Ming-Horng
Format:	Artikel
Sprache:	eng
Schlagworte:	Apoptosis Biological activity Biomarkers Blood-brain barrier Brain cancer Brain tumors Chemotherapy Clinical trials Deoxyribonucleic acid DNA DNA repair Drug delivery Drugs Glioblastoma Immunotherapy Medical prognosis Monoclonal antibodies Nanoparticles Nanotechnology Permeability Radiation therapy Review Stem cells Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!